Wordt geladen...
PARP inhibitor Olaparib increases the sensitization to radiotherapy in FaDu cells
Radioresistance causes a major problem for improvement of outcomes of patients treated with radiation. Targeting for DNA repair deficient mechanisms is a hallmark of sensitization to resistance. We tested whether Olaparib, a (poly) ADP‐ribose polymerase (PARP) inhibitor, can sensitize the radioresis...
Bewaard in:
| Gepubliceerd in: | J Cell Mol Med |
|---|---|
| Hoofdauteurs: | , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7028864/ https://ncbi.nlm.nih.gov/pubmed/31957270 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.14929 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|